116 patients were evaluated. Clinical improvements were reported in the maiority of the patients (66.4%).
Improvements mainly included increased motor functioning with decreased spasticity, resulting in improved sitting, standing, walking and posture stability as well as an improvement in mental functions resulting in better communication.
Improvement of speech was mentioned by 28 patients and a major reduction or even absence of epileptic seizures during the recorded post-treatment period was reported by 11 responders.
More than 90% of all the improvements started within 8 weeks after the application of autologous stem cells.